198 related articles for article (PubMed ID: 20846114)
1. Potential use of vanadium compounds in therapeutics.
Barrio DA; Etcheverry SB
Curr Med Chem; 2010; 17(31):3632-42. PubMed ID: 20846114
[TBL] [Abstract][Full Text] [Related]
2. Vanadium and bone development: putative signaling pathways.
Barrio DA; Etcheverry SB
Can J Physiol Pharmacol; 2006 Jul; 84(7):677-86. PubMed ID: 16998531
[TBL] [Abstract][Full Text] [Related]
3. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
4. Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets.
Conconi MT; DeCarlo E; Vigolo S; Grandi C; Bandoli G; Sicolo N; Tamagno G; Parnigotto PP; Nussdorfer GG
Horm Metab Res; 2003 Jul; 35(7):402-6. PubMed ID: 12931270
[TBL] [Abstract][Full Text] [Related]
5. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
6. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
7. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review.
Scior T; Guevara-García A; Bernard P; Do QT; Domeyer D; Laufer S
Mini Rev Med Chem; 2005 Nov; 5(11):995-1008. PubMed ID: 16307529
[TBL] [Abstract][Full Text] [Related]
8. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds.
Crans DC
J Inorg Biochem; 2000 May; 80(1-2):123-31. PubMed ID: 10885472
[TBL] [Abstract][Full Text] [Related]
9. Nutritional factors that can favorably influence the glucose/insulin system: vanadium.
Verma S; Cam MC; McNeill JH
J Am Coll Nutr; 1998 Feb; 17(1):11-8. PubMed ID: 9477384
[TBL] [Abstract][Full Text] [Related]
10. The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds.
Niu X; Xiao R; Wang N; Wang Z; Zhang Y; Xia Q; Yang X
Curr Top Med Chem; 2016; 16(8):811-22. PubMed ID: 26311429
[TBL] [Abstract][Full Text] [Related]
11. [Insulin-mimetic property of vanadium compounds].
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
[TBL] [Abstract][Full Text] [Related]
12. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
13. Developing Vanadium as an Antidiabetic or Anticancer Drug: A Clinical and Historical Perspective.
Crans DC; Henry L; Cardiff G; Posner BI
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855109
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and medical importance of vanadium compounds.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Acta Biochim Pol; 2012; 59(2):195-200. PubMed ID: 22693688
[TBL] [Abstract][Full Text] [Related]
15. Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection.
Bhuiyan MS; Shioda N; Fukunaga K
Expert Opin Ther Targets; 2008 Oct; 12(10):1217-27. PubMed ID: 18781821
[TBL] [Abstract][Full Text] [Related]
16. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of insulin-mimetic vanadium complexes.
Sakurai H; Yasui H; Adachi Y
Expert Opin Investig Drugs; 2003 Jul; 12(7):1189-203. PubMed ID: 12831353
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection by vanadium compounds targeting Akt-mediated signaling.
Bhuiyan MS; Fukunaga K
J Pharmacol Sci; 2009 May; 110(1):1-13. PubMed ID: 19423951
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
20. [Vanadium derivatives--a new source of antidiabetic drugs].
Dănilă G; Lupaşcu D
Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):74-7. PubMed ID: 10756929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
